New hope for rare brain disease: phase 3 trial of NIO752 underway
NCT ID NCT07498426
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests an experimental drug called NIO752 in 300 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and balance. Participants are randomly assigned to receive either the drug or a placebo. After the main study, everyone can receive the drug in an open-label extension. The goal is to see if NIO752 can slow the disease and improve daily function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE SUPRANUCLEAR PALSY RICHARDSON SYNDROME (PSP-RS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CenExcel Rocky Mtn Clin Research
RECRUITINGEnglewood, Colorado, 80113, United States
-
Klinik für Neurologie (Schwerpunkt Neurodegeneration)
RECRUITINGUlm, 89081, Germany
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic Arizona
RECRUITINGScottsdale, Arizona, 85259, United States
-
Mayo Jacksonville
RECRUITINGJacksonville, Florida, 32224, United States
-
Novartis Investigative Site
RECRUITINGWestmead, New South Wales, 2145, Australia
-
Novartis Investigative Site
RECRUITINGMelbourne, Victoria, 3004, Australia
-
Novartis Investigative Site
RECRUITINGShanghai, 200040, China
-
Novartis Investigative Site
RECRUITINGSuzhou, 215000, China
-
Novartis Investigative Site
RECRUITINGCaen, 14033, France
-
Novartis Investigative Site
RECRUITINGCréteil, 94010, France
-
Novartis Investigative Site
RECRUITINGLille, 59037, France
-
Novartis Investigative Site
RECRUITINGMarseille, 13885, France
-
Novartis Investigative Site
RECRUITINGNantes, 44093, France
-
Novartis Investigative Site
RECRUITINGParis, 75013, France
-
Novartis Investigative Site
RECRUITINGRennes, 35033, France
-
Novartis Investigative Site
RECRUITINGToulouse, 31059, France
-
Novartis Investigative Site
RECRUITINGMunich, Bavaria, 81377, Germany
-
Novartis Investigative Site
RECRUITINGWürzburg, Bavaria, 97080, Germany
-
Novartis Investigative Site
RECRUITINGBonn, North Rhine-Westphalia, 53127, Germany
-
Novartis Investigative Site
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
-
Novartis Investigative Site
RECRUITINGDresden, Saxony, 01307, Germany
-
Novartis Investigative Site
RECRUITINGLeipzig, Saxony, 04103, Germany
-
Novartis Investigative Site
RECRUITINGBeelitz, 14547, Germany
-
Novartis Investigative Site
RECRUITINGBerlin, 13353, Germany
-
Novartis Investigative Site
RECRUITINGStadtroda, 07646, Germany
-
Novartis Investigative Site
RECRUITINGTübingen, 72076, Germany
-
Novartis Investigative Site
RECRUITINGMilan, MI, 20133, Italy
-
Novartis Investigative Site
RECRUITINGRoma, RM, 00168, Italy
-
Novartis Investigative Site
RECRUITINGKodaira, Tokyo, 187-8551, Japan
-
Novartis Investigative Site
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Novartis Investigative Site
RECRUITINGNijmegen, 6525 GA, Netherlands
-
Novartis Investigative Site
RECRUITINGSeoul, 03722, South Korea
-
Novartis Investigative Site
RECRUITINGPozuelo de Alarcón, Madrid, 28223, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08036, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08041, Spain
-
Novartis Investigative Site
RECRUITINGLas Palmas GC, 35010, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28009, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28034, Spain
-
Novartis Investigative Site
RECRUITINGMadrid, 28041, Spain
-
Novartis Investigative Site
RECRUITINGSeville, 41013, Spain
-
Univ of California San Francisco
RECRUITINGSan Francisco, California, 94158, United States